0001628280-23-040450.txt : 20231201 0001628280-23-040450.hdr.sgml : 20231201 20231201161547 ACCESSION NUMBER: 0001628280-23-040450 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230131 FILED AS OF DATE: 20231201 DATE AS OF CHANGE: 20231201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fox-Colis Aaron CENTRAL INDEX KEY: 0001963698 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21088 FILM NUMBER: 231459709 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fresh Tracks Therapeutics, Inc. CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (720) 505-4755 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: Brickell Biotech, Inc. DATE OF NAME CHANGE: 20190830 FORMER COMPANY: FORMER CONFORMED NAME: VICAL INC DATE OF NAME CHANGE: 19940211 3 1 wk-form3_1701465332.xml FORM 3 X0206 3 2023-01-31 0 0000819050 Fresh Tracks Therapeutics, Inc. FRTX 0001963698 Fox-Colis Aaron 2000 CENTRAL AVENUE, SUITE 100 BOULDER CO 80301 0 1 0 0 VP of Finance & CAO Common Stock 110.44 D Stock Option (right to buy) 36 2021-09-15 2030-09-15 Common Stock 195 D Stock Option (right to buy) 40.50 2022-06-14 2031-06-14 Common Stock 174 D Stock Option (right to buy) 11.70 2023-05-05 2032-05-05 Common Stock 800 D Stock Option (right to buy) 6.03 2023-06-16 2032-06-16 Common Stock 2222 D Restricted Stock Units Common Stock 8000 D Includes 74 shares acquired under the Fresh Tracks Therapeutics, Inc. Employee Stock Purchase Plan. The stock options vested 25% on this date, the first anniversary of the date of grant, and the remainder are vesting in equal monthly installments over the following three years. The restricted stock units vest in full on January 24, 2024, the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of issuer common stock upon settlement. Exhibit 24 - Power of Attorney /s/ Griffin D. Foster, Attorney-in-Fact for Aaron Fox-Collis (power of attorney filed herewith) 2023-12-01 EX-24.1 2 powerofattorney-afc.htm EX-24.1 Document

POWER OF ATTORNEY

For Executing Form ID and Forms 3, 4, 5 and 144

The undersigned hereby constitutes and appoints each of Jonathan Zimmerman, Christine Long, Griffin Foster and Tyler Griffin, signing singly, as his true and lawful attorney-in-fact, for such period of time that the undersigned is required to file reports pursuant to Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or Rule 144 of the Securities Act of 1933, as amended (the "Securities Act"), due to his affiliation with Fresh Tracks Therapeutics, Inc., a Delaware corporation, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact, to:

1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Exchange Act or any rule or regulation of the SEC;

2) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the SEC Forms 3, 4, 5 and 144 and any amendments to previously filed forms in accordance with Section 16(a) of the Exchange Act or Rule 144 of the Securities Act and the rules thereunder;

3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Form ID or Forms 3, 4, 5 and 144 and the timely filing of such form with the SEC and any other authority as required by law; and

4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of or legally required by the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his or her discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or his or her substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the


request of the undersigned, are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act or Rule 144 of the Securities Act.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 1st day of December, 2023.

/s/ Aaron Fox-Collis
Aaron Fox-Collis